Approval · Notice of Compliance 33992 · 2024
PMS-VANCOMYCIN: Notice of Compliance 33992
Issued September 10, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33992
- Date
- September 10, 2024
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to Product Monograph (to align with CRP approved PM)
- Canadian reference product
- VANCOCIN (Merus Labs Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-VANCOMYCIN | Not yet assigned | — |
Medicinal ingredients
- VANCOMYCIN HYDROCHLORIDE 125 MG per CAP
- VANCOMYCIN HYDROCHLORIDE 250 MG per CAP